Delivery Order SPE2DR25D6028-SPE2DR26FASTN
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $13,424.46 for a kit of Lupron Depot (leuprolide acetate), a hormone treatment medication, under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on July 23, 2025, with an ultimate completion date of the same day, represents a competitively awarded, non-set-aside contract. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,717.61 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with a completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be performed at the contractor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a $17,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with an ultimate completion date of July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits with a firm fixed price value of $4,567.20. This delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. The product will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Lupron Depot 45 mg 6-month kits, with a ceiling value of $1,371.86. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract is not set-aside and was awarded competitively to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,915.36 on December 2, 2025, for the supply of Lupron Depot 22.5 mg 3-month kits, with an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $89,527.69 on September 19, 2025, for a kit of Lupron Depot-AD 1S, a hormone treatment medication. The contract is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,337.16 on December 8, 2025, for the supply of Lupron Depot 22.5 mg 3-month kits with an ultimate completion date of December 9, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,743.72 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lupron Depot 45 mg six-month kits. The contract is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lupron Depot 11.25 mg three-month kits valued at $24,361.39. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of November 7, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASTNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Lupron Depot-AD 1S, a leuprolide acetate product used in hormone treatment therapies. This firm fixed-price delivery order has a ceiling value of $44,772.88 and is scheduled for completion by January 13, 2026. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which provides comprehensive pharmaceutical supply support valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical supplies to military and veteran healthcare systems. The company maintains extensive experience fulfilling DLA requirements across multiple therapeutic domains, with its federal contract portfolio demonstrating capability to deliver everything from routine pharmaceutical commodities to specialized medical products. This particular award supports the Defense Health Agency and other government healthcare systems' ongoing pharmaceutical supply requirements through the DLA Troop Support's comprehensive global pharmaceutical support program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.8k | 12/14/25 |